386 related articles for article (PubMed ID: 11061495)
1. Sensitization to insulin in adolescent girls to normalize hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism after precocious pubarche.
Ibáñez L; Valls C; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2000 Oct; 85(10):3526-30. PubMed ID: 11061495
[TBL] [Abstract][Full Text] [Related]
2. Treatment of hirsutism, hyperandrogenism, oligomenorrhea, dyslipidemia, and hyperinsulinism in nonobese, adolescent girls: effect of flutamide.
Ibáñez L; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2000 Sep; 85(9):3251-5. PubMed ID: 10999817
[TBL] [Abstract][Full Text] [Related]
3. Early metformin therapy (age 8-12 years) in girls with precocious pubarche to reduce hirsutism, androgen excess, and oligomenorrhea in adolescence.
Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2011 Aug; 96(8):E1262-7. PubMed ID: 21632811
[TBL] [Abstract][Full Text] [Related]
4. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation.
Ibáñez L; Valls C; Ferrer A; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2002 Jun; 87(6):2870-4. PubMed ID: 12050266
[TBL] [Abstract][Full Text] [Related]
5. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment.
Ibáñez L; Valls C; Marcos MV; Ong K; Dunger DB; De Zegher F
J Clin Endocrinol Metab; 2004 Sep; 89(9):4331-7. PubMed ID: 15356029
[TBL] [Abstract][Full Text] [Related]
6. Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism.
Ibáñez L; Valls C; Ferrer A; Marcos MV; Rodriguez-Hierro F; de Zegher F
J Clin Endocrinol Metab; 2001 Aug; 86(8):3595-8. PubMed ID: 11502783
[TBL] [Abstract][Full Text] [Related]
7. Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism.
Ibáñez L; Potau N; Ferrer A; Rodriguez-Hierro F; Marcos MV; De Zegher F
J Clin Endocrinol Metab; 2002 Dec; 87(12):5702-5. PubMed ID: 12466374
[TBL] [Abstract][Full Text] [Related]
8. Low-dose flutamide-metformin therapy reverses insulin resistance and reduces fat mass in nonobese adolescents with ovarian hyperandrogenism.
Ibáñez L; Ong K; Ferrer A; Amin R; Dunger D; de Zegher F
J Clin Endocrinol Metab; 2003 Jun; 88(6):2600-6. PubMed ID: 12788862
[TBL] [Abstract][Full Text] [Related]
9. Adrenal hyperandrogenism in adolescent girls with a history of low birthweight and precocious pubarche.
Ibáñez L; Potau N; Marcos MV; De Zegher F
Clin Endocrinol (Oxf); 2000 Oct; 53(4):523-7. PubMed ID: 11012579
[TBL] [Abstract][Full Text] [Related]
10. Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia.
Genazzani AD; Lanzoni C; Ricchieri F; Baraldi E; Casarosa E; Jasonni VM
Gynecol Endocrinol; 2007 Mar; 23(3):146-52. PubMed ID: 17454168
[TBL] [Abstract][Full Text] [Related]
11. Precocious pubarche, hyperinsulinism, and ovarian hyperandrogenism in girls: relation to reduced fetal growth.
Ibáñez L; Potau N; Francois I; de Zegher F
J Clin Endocrinol Metab; 1998 Oct; 83(10):3558-62. PubMed ID: 9768664
[TBL] [Abstract][Full Text] [Related]
12. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche.
Ibáñez L; Potau N; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 1999 Dec; 84(12):4602-6. PubMed ID: 10599726
[TBL] [Abstract][Full Text] [Related]
13. Metformin treatment for four years to reduce total and visceral fat in low birth weight girls with precocious pubarche.
Ibáñez L; López-Bermejo A; Díaz M; Marcos MV; de Zegher F
J Clin Endocrinol Metab; 2008 May; 93(5):1841-5. PubMed ID: 18319306
[TBL] [Abstract][Full Text] [Related]
14. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
Ibáñez L; Ferrer A; Ong K; Amin R; Dunger D; de Zegher F
J Pediatr; 2004 Jan; 144(1):23-9. PubMed ID: 14722514
[TBL] [Abstract][Full Text] [Related]
15. Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity.
Ibáñez L; de Zegher F
J Clin Endocrinol Metab; 2004 Apr; 89(4):1592-7. PubMed ID: 15070917
[TBL] [Abstract][Full Text] [Related]
16. Precocious pubarche in girls and the development of androgen excess.
Ibáñez L; Potau N; Dunger D; de Zegher F
J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1261-3. PubMed ID: 11117666
[TBL] [Abstract][Full Text] [Related]
17. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
18. Premature pubarche, ovarian hyperandrogenism, hyperinsulinism and the polycystic ovary syndrome: from a complex constellation to a simple sequence of prenatal onset.
Ibáñez L; de Zegher F; Potau N
J Endocrinol Invest; 1998 Oct; 21(9):558-66. PubMed ID: 9856410
[TBL] [Abstract][Full Text] [Related]
19. Fat distribution in non-obese girls with and without precocious pubarche: central adiposity related to insulinaemia and androgenaemia from prepuberty to postmenarche.
Ibáñez L; Ong K; de Zegher F; Marcos MV; del Rio L; Dunger DB
Clin Endocrinol (Oxf); 2003 Mar; 58(3):372-9. PubMed ID: 12608944
[TBL] [Abstract][Full Text] [Related]
20. Metabolic features of polycystic ovary syndrome are found in adolescent girls with hyperandrogenism.
Apter D; Bützow T; Laughlin GA; Yen SS
J Clin Endocrinol Metab; 1995 Oct; 80(10):2966-73. PubMed ID: 7559882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
